Molecular and cell signaling targets for PTSD pathophysiology and pharmacotherapy - Test2 - elhamkhani - TriplyDB

Molecular and cell signaling targets for PTSD pathophysiology and pharmacotherapy

Molecular and cell signaling targets for PTSD pathophysiology and pharmacotherapy

http://www.wikidata.org/entity/Q26860173

about

Eyeblink classical conditioning and post-traumatic stress disorder - a model systems approach.The role of PKC signaling in CRF-induced modulation of startle.Single prolonged stress enhances hippocampal glucocorticoid receptor and phosphorylated protein kinase B levels Caveolin-1 regulates genomic action of the glucocorticoid receptor in neural stem cells.Brain transcriptome profiles in mouse model simulating features of post-traumatic stress disorder.Testing the nanoparticle-allostatic cross-adaptation-sensitization model for homeopathic remedy effects Alternative Splicing of the Pituitary Adenylate Cyclase-Activating Polypeptide Receptor PAC1: Mechanisms of Fine Tuning of Brain Activity.Sex differences in the locus coeruleus-norepinephrine system and its regulation by stress.FKBP5 and attention bias for threat: associations with hippocampal function and shape.Desensitization of human CRF2(a) receptor signaling governed by agonist potency and βarrestin2 recruitment.Pharmacotherapy in the aftermath of trauma; opportunities in the 'golden hours'.Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond.The Effect of Nicotine on HPA Axis Activity in Females is Modulated by the FKBP5 Genotype.Roles of PI3K/AKT/GSK3/mTOR Pathway in Cell Signaling of Mental Illnesses.A putative causal relationship between genetically determined female body shape and posttraumatic stress disorder.Risperidone Attenuates Modified Stress-Re-stress Paradigm-Induced Mitochondrial Dysfunction and Apoptosis in Rats Exhibiting Post-traumatic Stress Disorder-Like Symptoms.Sex differences in neurosteroid and hormonal responses to metyrapone in posttraumatic stress disorder.Role of FKBP5 in emotion processing: results on amygdala activity, connectivity and volume.Molecular and Cellular Effects of Traumatic Stress: Implications for PTSD.

P2860

Q28083084-A5E0B47A-D0A2-4BB0-99B5-E458EA25AA03 Q30429995-AE20E4B9-875B-4531-B988-903334DDD17F Q30443711-918F9EEE-2BF6-4019-92F4-9BDA7B9F394C Q33899866-7B5D65A7-C2D8-49E9-AC10-EF324CD886DD Q34472424-79A85911-4154-46E7-AA75-BEFB0C19DB54 Q36515121-EC5506D9-3CFE-4A47-B1C3-32A1F565E214 Q36860090-640AA7DB-67C9-49DC-B1AA-B7D2DC8CEC8C Q36923878-B3ED819D-1395-45AD-A725-742773C8ED75 Q37066740-562973B6-059A-47FB-991F-16D834E05AD5 Q37585127-76CF4941-8FD5-43BC-815E-FF4EEBF3F6BE Q38217123-0C27C7AD-FF58-4B46-BB37-BBAF8B561413 Q38832608-CA0EA523-EC16-415C-9B3A-4A7B2A7016DB Q38883411-79E89EB6-0B46-43F7-9AD0-6C86B0A63304 Q42527577-3E029DD8-C596-4217-8AFD-1CDDBE8CD9E1 Q45074061-45AC5E07-6BFF-4213-8256-A74878B91D2C Q47738847-B3FDB0B7-68B5-4818-BC2C-3907702B7BC5 Q47854333-7C0FA561-2DBF-4E78-B4E9-8A98D17E4CDE Q47885230-A1907246-605A-43BC-95BA-CC3D75CEB606 Q47931276-D0908024-F782-4938-9088-06DCF307FFF4

P2860

Molecular and cell signaling targets for PTSD pathophysiology and pharmacotherapy

http://www.wikidata.org/entity/Q26860173

description

2012 nî lūn-bûn

@nan

2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Molecular and cell signaling targets for PTSD pathophysiology and pharmacotherapy

@ast

Molecular and cell signaling targets for PTSD pathophysiology and pharmacotherapy

@en

Molecular and cell signaling targets for PTSD pathophysiology and pharmacotherapy

@nl

type

label

Molecular and cell signaling targets for PTSD pathophysiology and pharmacotherapy

@ast

Molecular and cell signaling targets for PTSD pathophysiology and pharmacotherapy

@en

Molecular and cell signaling targets for PTSD pathophysiology and pharmacotherapy

@nl

prefLabel

Molecular and cell signaling targets for PTSD pathophysiology and pharmacotherapy

@ast

Molecular and cell signaling targets for PTSD pathophysiology and pharmacotherapy

@en

Molecular and cell signaling targets for PTSD pathophysiology and pharmacotherapy

@nl

P1433

Q26860173-31823590-7ABF-431E-999D-0A9F417F6DD9

P1476

Q26860173-4230EE79-4485-410D-BAE0-2D7FC0865AB4

P2093

Q26860173-0D7EDF8F-E913-4F97-85CB-6FE0438021F1

Q26860173-4C172B9D-C638-472A-8DA2-2BB33BDF074D

Q26860173-52E93FB8-7F4A-48A3-B195-3785CCAF03EE

Q26860173-93FCB40D-2ADC-4981-82D9-0CA0AC7191D2

Q26860173-CD12F71C-5CD5-4278-BB34-2880FD4D90C3

Q26860173-EA420188-B2D8-41EA-86E2-F8CD58294C70

P2860

Q26860173-0F2AAB4E-9115-4090-B316-17CB3DA6AEE8

Q26860173-12750C7D-6CC3-480D-80A0-2ECA5315AC9C

Q26860173-13194C8E-92F8-40C5-864F-73459D1542A6

Q26860173-1C0F9513-D33C-471B-86D9-08B9D7E72D62

Q26860173-27A7CBF9-AE85-49AA-827B-0D67BF9E4AAF

Q26860173-2839C0DB-C180-48CB-AC13-CB07C8A6375C

Q26860173-2873A950-AF00-49F9-991E-00CD29BFE33F

Q26860173-29F09D9A-1937-42C4-B6FC-856E4FB0F073

Q26860173-32480605-9AC4-4DAA-9DE8-99A79B657564

Q26860173-3F81940F-C947-4009-A397-AC9A4C432B3D

P304

Q26860173-3FB1D900-2A7E-4C2F-802E-0DC3FCBE54E6

P31

Q26860173-F1629037-6ED0-4FD4-A3B4-95941CBEA04E

P356

Q26860173-423D8A76-A7DA-4D76-8C03-D221A18AE0C8

P407

Q26860173-CD84A7F4-FEEF-4453-A6CA-E25CD38A663F

P433

Q26860173-E4518293-FA01-4282-8A9F-F3937640494F

P478

Q26860173-A5ECA0DA-90A1-452C-9F16-C303F8E84D9E

P577

Q26860173-D59270BC-CE6D-41B1-8EFE-9A7920E4AE36

P5875

Q26860173-83637291-1468-4818-ACA2-391270C2E33E

P698

Q26860173-F7FC74F4-F4DB-4D3A-9C6A-2AFFFDE83390

P921

Q26860173-7E02DE56-FE35-42E7-B631-D0665866687A

Q26860173-9273E3BB-754B-4531-AE21-E9A8CAB96C04

Q26860173-96688BAF-6D92-4088-BA57-7BB4E6D9CCFB

P932

Q26860173-8D80CF92-0959-43F4-8E63-012BA940C9D5

P356

J.NEUROPHARM.2011.11.007

P1433

Neuropharmacology

P1476

Molecular and cell signaling targets for PTSD pathophysiology and pharmacotherapy

@en

P2093

Frank M. Dautzenberg

http://www.w3.org/2001/XMLSchema#string

J. Alberto Olivares-Reyes

http://www.w3.org/2001/XMLSchema#string

James B. Lohr

http://www.w3.org/2001/XMLSchema#string

Richard L. Hauger

http://www.w3.org/2001/XMLSchema#string

Robert H. Oakley

http://www.w3.org/2001/XMLSchema#string

Sandra Braun

http://www.w3.org/2001/XMLSchema#string

P2860

Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor

PTSD and gene variants: new pathways and new thinking.

Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults

Corticotropin Releasing Factor (CRF) activation of NF-kappaB-directed transcription in leukocytes

Gene expression patterns associated with posttraumatic stress disorder following exposure to the World Trade Center attacks

Phosphorylation and desensitization of human endothelin A and B receptors. Evidence for G protein-coupled receptor kinase specificity

Alterations in 5-HT1B receptor function by p11 in depression-like states

Childhood trauma associated with short leukocyte telomere length in posttraumatic stress disorder

Posttraumatic stress disorder in the National Comorbidity Survey

Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder

P304

705-14

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NEUROPHARM.2011.11.007

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

62

http://www.w3.org/2001/XMLSchema#string

P577

2012-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

229316896

http://www.w3.org/2001/XMLSchema#string

P698

22122881

http://www.w3.org/2001/XMLSchema#string

P921

pathophysiology

post-traumatic stress disorder

pharmacotherapy

P932

3545643

http://www.w3.org/2001/XMLSchema#string